Deltex Medical Group PLC DTXMF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.99
- Bid/Ask
- $0.00 / $0.79
- Market Cap
- $5.69 Mil
- Volume/Avg
- 10,000 / 32,500
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.60
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Deltex Medical Group PLC is a British manufacturer of Fluid Management devices, which include the ODM and now ODM+ haemodynamic monitoring systems. The company has developed the gold standard for haemodynamic monitoring with oesophageal Doppler technology, which is marketed as TrueVue Doppler and often generically referred to by clinicians as ODM. The company's initial and principal technology is Doppler-based ultrasound oesophageal haemodynamic monitoring.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 35
- Website
- https://www.deltexmedical.com
Valuation
|
Metric
|
DTXMF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.36 |
Price/Sales | 1.60 |
Price/Cash Flow | — |
Price/Earnings
DTXMF
Financial Strength
|
Metric
|
DTXMF
|
|---|---|
Quick Ratio | 1.04 |
Current Ratio | 1.89 |
Interest Coverage | −4.57 |
Quick Ratio
DTXMF
Profitability
|
Metric
|
DTXMF
|
|---|---|
Return on Assets (Normalized) | −14.22% |
Return on Equity (Normalized) | −34.60% |
Return on Invested Capital (Normalized) | −13.52% |
Return on Assets
DTXMF
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Mhqrgfh | Tlbvgfv | $183.1 Bil | |||
| Stryker Corp
SYK
| Jmgddhsqh | Ywdv | $126.3 Bil | |||
| Boston Scientific Corp
BSX
| Ckpfffkvy | Jcqktp | $110.1 Bil | |||
| Medtronic PLC
MDT
| Scwrcswy | Wzbrcm | $100.9 Bil | |||
| Edwards Lifesciences Corp
EW
| Qljgvznsjp | Ssljkvy | $37.6 Bil | |||
| DexCom Inc
DXCM
| Csklkywl | Qhp | $25.6 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Bztwmtqt | Zxfxwvj | $24.1 Bil | |||
| Steris PLC
STE
| Wynxpjvgx | Jmtdyl | $23.0 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Xgggkthkc | Vdrq | $22.9 Bil | |||
| Align Technology Inc
ALGN
| Djpqtykj | Ctyxf | $16.6 Bil |